Particle.news
Download on the App Store

Normalizing Blood Sugar Tied to Halved Cardiovascular Risk in Prediabetes

A post‑hoc reanalysis of U.S. and Chinese cohorts identifies remission as the protective factor, with ≤97 mg/dL fasting glucose offering a simple target.

Overview

  • The Lancet Diabetes & Endocrinology paper reports a harmonized reanalysis of DPPOS and DaQingDPOS, pooling more than 2,400 participants followed for roughly 20 to 30 years.
  • Achieving sustained remission of prediabetes was associated with a 58% lower risk of cardiovascular death or hospitalization for heart failure.
  • Rates of major adverse cardiovascular events, including heart attack and stroke, were 42% lower among participants who reached remission.
  • Findings were consistent across the U.S. and Chinese studies, reinforcing that risk reduction tracks with normalized glucose rather than lifestyle programs alone.
  • Researchers highlight a fasting glucose threshold of ≤97 mg/dL as a practical marker for lower risk and urge considering remission as a formal prevention target, while noting policy gaps cited in Germany.